CircRNA0007766 accelerates cancer progression via miR-34c-5p/cyclin D1 axis in adenocarcinoma of the esophagogastric junction (AEG)

Hayakawa, 2016, Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?, Nat. Rev. Cancer, 16, 305, 10.1038/nrc.2016.24 Siewert, 1998, Classification of adenocarcinoma of the oesophagogastric junction, Br. J. Surg., 85, 1457, 10.1046/j.1365-2168.1998.00940.x Pectasides, 2018, Genomic heterogeneity as a barrier to precision medicine in gastroesophageal adenocarcinoma, Cancer Discov., 8, 37, 10.1158/2159-8290.CD-17-0395 Crew, 2004, Epidemiology of upper gastrointestinal malignancies, Semin. Oncol., 31, 450, 10.1053/j.seminoncol.2004.04.021 Siegel, 2019, Cancer statistics, 2019, CA Cancer J. Clin., 69, 7, 10.3322/caac.21551 Nagaraja, 2019, Genomics and targeted therapies in gastroesophageal adenocarcinoma, Cancer Discov., 9, 1656, 10.1158/2159-8290.CD-19-0487 Lynch, 2005, Gastric cancer: new genetic developments, J. Surg. Oncol., 90, 114, 10.1002/jso.20214 Balihodzic, 2022, Non-coding RNAs and ferroptosis: potential implications for cancer therapy, Cell Death Differ., 29, 1094, 10.1038/s41418-022-00998-x Chen, 2020, The expanding regulatory mechanisms and cellular functions of circular RNAs, Nat. Rev. Mol. Cell Biol., 21, 475, 10.1038/s41580-020-0243-y Huang, 2017, Recent progress in circular RNAs in human cancers, Cancer Lett., 404, 8, 10.1016/j.canlet.2017.07.002 Liu, 2022, Circular RNAs: characterization, cellular roles, and applications, Cell, 185, 2016, 10.1016/j.cell.2022.04.021 Kristensen, 2022, The emerging roles of circRNAs in cancer and oncology, Nat. Rev. Clin. Oncol., 19, 188, 10.1038/s41571-021-00585-y Salmena, 2011, A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?, Cell, 146, 353, 10.1016/j.cell.2011.07.014 Yu, 2022, Circular RNA hsa_circ_0002360 promotes proliferation and invasion and inhibits oxidative stress in gastric Cancer by sponging miR-629-3p and regulating the PDLIM4 expression, Oxidative Med. Cell. Longev., 2022, 2775433, 10.1155/2022/2775433 Shi, 2020, Circular RNA LPAR3 sponges microRNA-198 to facilitate esophageal cancer migration, invasion, and metastasis, Cancer Sci., 111, 2824, 10.1111/cas.14511 Prieto, 2008, Human gene coexpression landscape: confident network derived from tissue transcriptomic profiles, PLoS One, 3, 10.1371/journal.pone.0003911 Lai, 2019, Circular RNA 0047905 acts as a sponge for microRNA4516 and microRNA1227-5p, initiating gastric cancer progression, Cell Cycle, 18, 1560, 10.1080/15384101.2019.1618122 Schmittgen, 2008, Analyzing real-time PCR data by the comparative C(T) method, Nat. Protoc., 3, 1101, 10.1038/nprot.2008.73 Gertler, 2011, How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer?, Am. J. Surg. Pathol., 35, 1512, 10.1097/PAS.0b013e3182294764 Liu, 2015, Comparison on Clinicopathological features and prognosis between Esophagogastric junctional adenocarcinoma (Siewert II/III types) and distal gastric adenocarcinoma: retrospective cohort study, a single institution, high volume experience in China, Medicine, 94 Kristensen, 2019, The biogenesis, biology and characterization of circular RNAs, Nat. Rev. Genet., 20, 675, 10.1038/s41576-019-0158-7 Li, 2017, CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells, EMBO Rep., 18, 1646, 10.15252/embr.201643581 Huang, 2015, cir-ITCH plays an inhibitory role in colorectal cancer by regulating the Wnt/β-catenin pathway, PLoS One, 10 Fu, 2017, Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma, Oncotarget, 8, 43878, 10.18632/oncotarget.16709 Jin, 2017, Circular RNA hsa-circ-0016347 promotes proliferation, invasion and metastasis of osteosarcoma cells, Oncotarget, 8, 25571, 10.18632/oncotarget.16104 Chen, 2018, Circular RNA: an emerging non-coding RNA as a regulator and biomarker in cancer, Cancer Lett., 418, 41, 10.1016/j.canlet.2018.01.011 Hunter, 1994, Cyclins and cancer. II: cyclin D and CDK inhibitors come of age, Cell, 79, 573, 10.1016/0092-8674(94)90543-6 Qie, 2016, Cyclin D1, cancer progression, and opportunities in cancer treatment, J. Mol. Med. (Berl.), 94, 1313, 10.1007/s00109-016-1475-3 Musgrove, 2011, Cyclin D as a therapeutic target in cancer, Nat. Rev. Cancer, 11, 558, 10.1038/nrc3090 Benzeno, 2006, Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1, Oncogene, 25, 6291, 10.1038/sj.onc.1209644 Montalto, 2020, Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma, Cells, 9, 10.3390/cells9122648 Forest, 2021, Cyclin D1 expression in ganglioglioma, pleomorphic xanthoastrocytoma and pilocytic astrocytoma, Exp. Mol. Pathol., 121, 104652, 10.1016/j.yexmp.2021.104652 Hansen, 2013, Natural RNA circles function as efficient microRNA sponges, Nature, 495, 384, 10.1038/nature11993 Nakuluri, 2019, Hypoxia induces ZEB2 in podocytes: implications in the pathogenesis of proteinuria, J. Cell. Physiol., 234, 6503, 10.1002/jcp.27387 Nakuluri, 2019, Cerebral ischemia induces TRPC6 via HIF1α/ZEB2 axis in the glomerular podocytes and contributes to proteinuria, Sci. Rep., 9, 17897, 10.1038/s41598-019-52872-5